These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30040505)

  • 1. The value of the 24-h proteinuria in evaluating the severity of preeclampsia and predicting its adverse maternal outcomes.
    Li B; Lin L; Yang H; Zhu Y; Wei Y; Li X; Chen D; Zhao X; Cui S; Ding H; Ding G; Meng H; Wei H; Sun X; Xin H
    Hypertens Pregnancy; 2018 Aug; 37(3):118-125. PubMed ID: 30040505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualitative Analysis of Diagnostic Value of 24-h Proteinuria for Preeclampsia.
    Zhuang X; Chen YY; Zhou Q; Lin JH
    Chin Med J (Engl); 2015 Nov; 128(22):2998-3002. PubMed ID: 26608977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinuria in pre-eclampsia: how much matters?
    Chan P; Brown M; Simpson JM; Davis G
    BJOG; 2005 Mar; 112(3):280-5. PubMed ID: 15713140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinuria may be an indicator of adverse pregnancy outcomes in patients with preeclampsia: a retrospective study.
    Lei T; Qiu T; Liao W; Li K; Lai X; Huang H; Yuan R; Chen L
    Reprod Biol Endocrinol; 2021 May; 19(1):71. PubMed ID: 33990220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIERS proteinuria: relationship with adverse maternal and perinatal outcome.
    Payne B; Magee LA; Côté AM; Hutcheon JA; Li J; Kyle PM; Menzies JM; Peter Moore M; Parker C; Pullar B; von Dadelszen P; Walters BN; ; von Dadelszen P; Magee LA; Douglas MJ; Walley KR; Russell JA; Lee SK; Gruslin A; Smith GN; Côté AM; Moutquin JM; Brown MA; Davis G; Walters BN; Sass N; Duan T; Zhou J; Mahajan S; Noovao A; McCowan LA; Kyle P; Moore MP; Bhutta SZ; Bhutta ZA; Hall ; Steyn DW; Broughton Pipkin F; Loughna P; Robson S; de Swiet M; Walker JJ; Grobman WA; Lindheimer MD; Roberts JM; Mark Ansermino J; Benton S; Cundiff G; Hugo D; Joseph KS; Lalji S; Li J; Lott P; Ouellet AB; Shaw D; Keith Still D; Tawagi G; Wagner B; Biryabarema C; Mirembe F; Nakimuli A; Tsigas E; Merialdi M; Widmer M
    J Obstet Gynaecol Can; 2011 Jun; 33(6):588-597. PubMed ID: 21846448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reappraisal of the relationship between 24-hour proteinuria and preeclampsia in terms of the maternal and perinatal outcomes.
    Yılmaz Baran Ş; Alemdaroğlu S; Durdağ GD; Yetkinel S; Yüksel Şimşek S; Kalaycı H; Şimşek E
    Hypertens Pregnancy; 2020 May; 39(2):82-88. PubMed ID: 32037908
    [No Abstract]   [Full Text] [Related]  

  • 7. Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? A retrospective cohort study.
    Elia EG; Robb AO; Hemming K; Price MJ; Riley RD; French-Constant A; Denison FC; Kilby MD; Morris RK; Stock SJ
    Acta Obstet Gynecol Scand; 2017 May; 96(5):580-588. PubMed ID: 28247485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of adverse maternal outcomes from pre-eclampsia and other hypertensive disorders of pregnancy: A systematic review.
    Ukah UV; De Silva DA; Payne B; Magee LA; Hutcheon JA; Brown H; Ansermino JM; Lee T; von Dadelszen P
    Pregnancy Hypertens; 2018 Jan; 11():115-123. PubMed ID: 29198742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How accurate are maternal symptoms in predicting impending complications in women with preeclampsia? A systematic review and meta-analysis.
    Thangaratinam S; Gallos ID; Meah N; Usman S; Ismail KM; Khan KS;
    Acta Obstet Gynecol Scand; 2011 Jun; 90(6):564-73. PubMed ID: 21355860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of 24-hour urinary protein and calcium for prediction of preeclampsia.
    Sirohiwal D; Dahiya K; Khaneja N
    Taiwan J Obstet Gynecol; 2009 Jun; 48(2):113-5. PubMed ID: 19574169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uric Acid as a predictor of adverse maternal and perinatal outcomes in women hospitalized with preeclampsia.
    Livingston JR; Payne B; Brown M; Roberts JM; Côté AM; Magee LA; von Dadelszen P;
    J Obstet Gynaecol Can; 2014 Oct; 36(10):870-877. PubMed ID: 25375299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prediction of adverse maternal outcomes in preeclampsia.
    von Dadelszen P; Magee LA; Devarakonda RM; Hamilton T; Ainsworth LM; Yin R; Norena M; Walley KR; Gruslin A; Moutquin JM; Lee SK; Russell JA
    J Obstet Gynaecol Can; 2004 Oct; 26(10):871-9. PubMed ID: 15507197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of risk prediction models for adverse maternal and neonatal outcomes in severe preeclampsia in a low-resource setting, Mpilo Central Hospital, Bulawayo, Zimbabwe.
    Ngwenya S; Jones B; Mwembe D; Nare H; Heazell AEP
    Pregnancy Hypertens; 2021 Mar; 23():18-26. PubMed ID: 33161225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting proteinuria in hypertensive pregnancies with urinary protein-creatinine or calcium-creatinine ratio.
    Rizk DE; Agarwal MM; Pathan JY; Obineche EN
    J Perinatol; 2007 May; 27(5):272-7. PubMed ID: 17453039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of the urinary protein:creatinine ratio for the detection of significant proteinuria in women with suspected preeclampsia.
    Bhide A; Rana R; Dhavilkar M; Amodio-Hernandez M; Deshpande D; Caric V
    Acta Obstet Gynecol Scand; 2015 May; 94(5):542-6. PubMed ID: 25737188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxygen saturation as a predictor of adverse maternal outcomes in women with preeclampsia.
    Millman AL; Payne B; Qu Z; Joanne Douglas M; Hutcheon JA; Lee T; Magee LA; Walley KR; von Dadelszen P;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):705-714. PubMed ID: 21749746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using clinical symptoms to predict adverse maternal and perinatal outcomes in women with preeclampsia: data from the PIERS (Pre-eclampsia Integrated Estimate of RiSk) study.
    Yen TW; Payne B; Qu Z; Hutcheon JA; Lee T; Magee LA; Walters BN; von Dadelszen P;
    J Obstet Gynaecol Can; 2011 Aug; 33(8):803-809. PubMed ID: 21846435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The predictive value of signs and symptoms in predicting adverse maternal and perinatal outcomes in severe preeclampsia in a low-resource setting, findings from a cross-sectional study at Mpilo Central Hospital, Bulawayo, Zimbabwe.
    Ngwenya S; Jones B; Mwembe D; Nare H; Heazell A
    Pregnancy Hypertens; 2020 Jul; 21():77-83. PubMed ID: 32450422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated proteinuria is a risk factor for pre-eclampsia: a retrospective analysis of the maternal and neonatal outcomes in women presenting with isolated gestational proteinuria.
    Shinar S; Asher-Landsberg J; Schwartz A; Ram-Weiner M; Kupferminc MJ; Many A
    J Perinatol; 2016 Jan; 36(1):25-9. PubMed ID: 26513453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of postpartum hemorrhage in women with gestational hypertension or mild preeclampsia at term.
    Koopmans CM; van der Tuuk K; Groen H; Doornbos JP; de Graaf IM; van der Salm PC; Porath MM; Kuppens SM; Wijnen EJ; Aardenburg R; van Loon AJ; Akerboom BM; van der Lans PJ; Mol BW; van Pampus MG;
    Acta Obstet Gynecol Scand; 2014 Apr; 93(4):399-407. PubMed ID: 24575790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.